Skip to main content

LSX World Congress


Date: September 14, 2023

IPO Workshop: “3 Ps” of Going Public – Preparation, Path, and Post Transaction

For companies, founders, and entrepreneurs considering entrance into the public markets, this session will focus on the “3 Ps” of going public – preparation, path, and post-transaction; and the different ways to go public in challenging markets. Are you and your board prepared?  What path is most appropriate for you: traditional or an alternative ‘going public avenue. How can you best prepare for success post-transaction?


To Prepare For A Successful Biotech IPO Or Reverse Merger

Any biotech company that has reached a certain size and is in need of investment will have to consider the critical question: is it time to go public? This discussion will focus all areas a biotech needs to be thinking about when considering an IPO.

  1. Why, when, and where?
  2. Closing a successful IPO/reverse merger
  3. Life after the IPO


Professional Cropped Rudy John Mintz

John T. Rudy


John T. Rudy is a Mintz Member who represents clients in capital markets transactions, securities, equity debt financings, and mergers and acquisitions. John's clients include public and private companies and investment banks. Before joining Mintz, he was an associate in a New York law firm.

Salar Roshan


Operating Partner, 3E Bioventures

Kimberly Ha


Founder & CEO, KKH Advisors

Shaun Bagai


CEO, RenovoRx